XPH Stock Summary and Trading Ideas (SPDR S&P Pharmaceuticals ETF | ARCA:XPH)

The SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the Index ).The S&P Pharmaceuticals Select Industry Index (the Index ) represents the pharmaceuticals segment of the S&P Total Market Index ( S&P TMI ). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the Pharmaceuticals sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the Select Industry Indices ), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ( GICS ).

SPDR S&P Pharmaceuticals ETF trades on the ARCA stock market under the symbol XPH.

As of April 19, 2024, XPH stock price climbed to $39.14 with 14,857 million shares trading.

XPH has a beta of 0.92, meaning it tends to be less sensitive to market movements. XPH has a correlation of 0.34 to the broad based SPY ETF.

XPH has a market cap of $189.84 million. This is considered a Micro Cap stock.

In the last 3 years, XPH stock traded as high as $53.82 and as low as $34.67.

XPH has underperformed the market in the last year with a price return of -5.3% while the SPY ETF gained +21.2%. XPH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -5.0% and -5.8%, respectively, while the SPY returned +4.3% and -3.5%, respectively.

XPH support price is $38.63 and resistance is $39.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XPH stock will trade within this expected range on the day.